Roferon-A is an injectible, recombinant pharmaceutical used to treat different types of leukemia, malignant melanoma, multiple myeloma, non-Hodgkin's lymphoma, AIDS-related sarcoma, and hepatitis.
- Description (Brief)
-
Roferon-A is an injectible, recombinant pharmaceutical used to treat different types of leukemia, malignant melanoma, multiple myeloma, non-Hodgkin's lymphoma, AIDS-related sarcoma, and hepatitis. It was discontinued in October 2007, as new therapies for the diseases it treated were developed.
-
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human interferon are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferon, which is harvested and used as the active ingredient in Roferon-A.
-
Object consists of a sealed white cardboard box with red and black printing. Box contains 10 single-use, 1 mL vials.
- Location
-
Currently not on view
- date made
-
ca 1988
- product expiration date
-
1988-04-01
- maker
-
Hoffmann-La Roche
-
Roche Laboratories
- ID Number
-
1987.0786.02
- accession number
-
1987.0786
- catalog number
-
1987.0786.02